These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 8486529

  • 21. Evaluation of gamma-enolase as a tumor marker for lung cancer.
    Fujita K, Haimoto H, Imaizumi M, Abe T, Kato K.
    Cancer; 1987 Aug 01; 60(3):362-9. PubMed ID: 3036329
    [Abstract] [Full Text] [Related]

  • 22. Aldolase C in neuroendocrine tumors: an immunohistochemical study.
    Inagaki H, Eimoto T, Haimoto H, Hosoda S, Kato K.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1993 Aug 01; 64(5):297-302. PubMed ID: 8287126
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Serum Hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma.
    Traeger L, Ellermann I, Wiethoff H, Ihbe J, Gallitz I, Eveslage M, Moritz R, Herrmann E, Schrader AJ, Steinbicker AU.
    BMC Cancer; 2019 Jan 15; 19(1):74. PubMed ID: 30646851
    [Abstract] [Full Text] [Related]

  • 26. Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients.
    Shioi K, Komiya A, Hattori K, Huang Y, Sano F, Murakami T, Nakaigawa N, Kishida T, Kubota Y, Nagashima Y, Yao M.
    Clin Cancer Res; 2006 Dec 15; 12(24):7339-46. PubMed ID: 17189405
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. High expression of fructose-bisphosphate aldolase A induces progression of renal cell carcinoma.
    Huang Z, Hua Y, Tian Y, Qin C, Qian J, Bao M, Liu Y, Wang S, Cao Q, Ju X, Wang Z, Gu M.
    Oncol Rep; 2018 Jun 15; 39(6):2996-3006. PubMed ID: 29693182
    [Abstract] [Full Text] [Related]

  • 29. Editorial Comment to Potential tumor markers of renal cell carcinoma: α-enolase for postoperative follow up, and galectin-1 and galectin-3 for primary detection.
    Ornellas AA.
    Int J Urol; 2013 May 15; 20(5):535-6. PubMed ID: 23113761
    [No Abstract] [Full Text] [Related]

  • 30. Clinicopathological significance of matrix metalloproteinase 2 protein expression in patients with renal cell carcinoma: A case-control study and meta-analysis.
    Liu Q, Zhang GW, Zhu CY, Wei JX, Tian X, Li Y, Li XD.
    Cancer Biomark; 2016 May 15; 16(2):281-9. PubMed ID: 26756619
    [Abstract] [Full Text] [Related]

  • 31. Serum amino acid levels as a biomarker for renal cell carcinoma.
    Mustafa A, Gupta S, Hudes GR, Egleston BL, Uzzo RG, Kruger WD.
    J Urol; 2011 Oct 15; 186(4):1206-12. PubMed ID: 21849193
    [Abstract] [Full Text] [Related]

  • 32. The significance of thymidine phosphorylase/platelet-derived endothelial cell growth factor activity in renal cell carcinoma.
    Mizutani Y, Wada H, Yoshida O, Fukushima M, Kawauchi A, Nakao M, Miki T.
    Cancer; 2003 Aug 15; 98(4):730-6. PubMed ID: 12910516
    [Abstract] [Full Text] [Related]

  • 33. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
    Bui MH, Seligson D, Han KR, Pantuck AJ, Dorey FJ, Huang Y, Horvath S, Leibovich BC, Chopra S, Liao SY, Stanbridge E, Lerman MI, Palotie A, Figlin RA, Belldegrun AS.
    Clin Cancer Res; 2003 Feb 15; 9(2):802-11. PubMed ID: 12576453
    [Abstract] [Full Text] [Related]

  • 34. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S, Shiina H, Enokida H, Hirata H, Kawamoto K, Kawakami T, Kikuno N, Tanaka Y, Majid S, Nakagawa M, Igawa M, Dahiya R.
    Clin Cancer Res; 2006 Dec 01; 12(23):6989-97. PubMed ID: 17145819
    [Abstract] [Full Text] [Related]

  • 35. Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).
    Wechsel HW, Petri E, Bichler KH, Feil G.
    Anticancer Res; 1999 Dec 01; 19(4A):2583-90. PubMed ID: 10470199
    [Abstract] [Full Text] [Related]

  • 36. Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis.
    Mizutani Y, Nakanishi H, Li YN, Matsubara H, Yamamoto K, Sato N, Shiraishi T, Nakamura T, Mikami K, Okihara K, Takaha N, Ukimura O, Kawauchi A, Nonomura N, Bonavida B, Miki T.
    Int J Oncol; 2007 Apr 01; 30(4):919-25. PubMed ID: 17332931
    [Abstract] [Full Text] [Related]

  • 37. Significance of amyloid A immunoexpression in the prognosis of renal cell carcinoma.
    Oz Atalay F, Aytac Vuruskan B, Vuruskan H.
    APMIS; 2016 Apr 01; 124(4):257-62. PubMed ID: 26750935
    [Abstract] [Full Text] [Related]

  • 38. Correlation of bFGF expression in renal cell cancer with clinical and histopathological features by tissue microarray analysis and measurement of serum levels.
    Horstmann M, Merseburger AS, von der Heyde E, Serth J, Wegener G, Mengel M, Feil G, Hennenlotter J, Nagele U, Anastasiadis A, Bokemeyer C, Stenzl A, Kuczyk M.
    J Cancer Res Clin Oncol; 2005 Nov 01; 131(11):715-22. PubMed ID: 16080018
    [Abstract] [Full Text] [Related]

  • 39. Tumor markers in human renal cell carcinoma.
    Kusama K, Asano M, Moro I, Sekine T, Kakizoe T, Tobisu K, Kishi K.
    Tumour Biol; 1991 Nov 01; 12(4):189-97. PubMed ID: 1871509
    [Abstract] [Full Text] [Related]

  • 40. Thymidine kinase activity in serum of renal cell carcinoma patients is a useful prognostic marker.
    Luo P, He E, Eriksson S, Zhou J, Hu G, Zhang J, Skog S.
    Eur J Cancer Prev; 2009 Jun 01; 18(3):220-4. PubMed ID: 19282758
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.